| 000 | 01856cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030601.0 | ||
| 008 | 120307s2011 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.28.Ph.D.2011.Ha.N | ||
| 100 | 0 | _aHani Abdelsalam Mahmoud Elmikaty | |
| 245 | 1 | 0 |
_aNeonatal fetuin-A and adiponectin levels in high risk pregnancies / _cHani Abdelsalam Mahmoud Elmikaty ; Supervised Iman Abdelsalam Seoud , Nagwa Abdallah Mahmoud , Heba Hani Abou Hussein |
| 246 | 1 | 5 | _aقياس مستوي الفتوين-أ و الاديبونيكتين في حديثي الولادة بعد الحمل ذو الخطورة العالية |
| 260 |
_aCairo : _bHani Abdelsalam Mahmoud Elmikaty , _c2011 |
||
| 300 |
_a284 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Pediatrics | ||
| 520 | _aFetuin-A, is produced by the liver and placenta a natural inhibitor of the insulin receptor tyrosine kinase in liver and skeletal muscle. Adiponectin is an adipocyte-derived peptide with anti-inflammatory effects. This study was conduucted on 80 newborn babies, Fetuin-A levels were found to be significantly high in all high risk groups. No significant differences in adiponectin levels were found. No correlation was found between Fetuin-A and adiponectin in all groups of the study | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAdiponectin | |
| 653 | 4 | _aFetuin-A | |
| 653 | 4 | _aHigh risk pregnancy | |
| 700 | 0 |
_aHeba Hani Abou Hussein , _eSupervisor |
|
| 700 | 0 |
_aIman Abdelsalam Seoud , _eSupervisor |
|
| 700 | 0 |
_aNagwa Abdallah Mahmoud , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c37747 _d37747 |
||